Press Releases about Sage Therapeutic Com
![](https://ml.globenewswire.com/media/5d514042-8326-4555-8ad7-f6cc765ecfcd/small/bl-new-logo-jpg.jpg)
![](https://mms.businesswire.com/media/20240902830879/en/805853/22/Robbins_LLP.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://mms.businesswire.com/media/20240830919919/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
![](https://mms.businesswire.com/media/20240829733952/en/1138077/5/RGRD_Logo_BusinessWire.jpg)
![](https://ml.globenewswire.com/media/5d514042-8326-4555-8ad7-f6cc765ecfcd/small/bl-new-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
![](https://mms.businesswire.com/media/20240829534595/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://mms.businesswire.com/media/20240804458886/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20240731771837/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20240726998773/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20240723520261/en/2194549/22/Biogen_Logo_Standard-rgb_R.jpg)
![](https://mms.businesswire.com/media/20240717928127/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20240610834762/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20240605254101/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20240507629601/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20240425567718/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20240416114636/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20240411131491/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20240227827709/en/1442032/5/Sage_Logo.jpg)
Sage Therapeutics to Present at Upcoming March Investor Conferences
February 28, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240214365148/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20240131967265/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20240106798395/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20240106899755/en/1442032/5/Sage_Logo.jpg)
Sage Therapeutics Announces Changes to Board of Directors
January 08, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240102349279/en/1442032/5/Sage_Logo.jpg)
![](https://www.marketbeat.com/logos/articles/med_20231220075859_biotech-stocks-tapping-into-unmet-mental-health-tr.jpg)
![](https://mms.businesswire.com/media/20231213368658/en/1969219/5/Biogen_Logo_Standard.jpg)
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
![](https://mms.businesswire.com/media/20231108180825/en/1442032/5/Sage_Logo.jpg)
Sage Therapeutics to Present at Upcoming November Investor Conferences
November 08, 2023
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.